Top compounds associated with response to INSL4


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG CCLE pan-cancer AAC 0.098 0.03
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.064 0.03
mRNA Dasatinib FIMM pan-cancer AAC 0.35 0.04
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.073 0.04
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.076 0.04
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.073 0.04
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.069 0.04
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.069 0.04
Download CSV